Real-time polymerase chain reaction (qPCR) was optimized for detecting Mycobacterium tuberculosis in sputum. Sputum was collected from patients (N = 112) with suspected pulmonary tuberculosis, tested by smear microscopy, decontaminated, and split into equal aliquots that were cultured in Lö wenstein-Jensen medium and tested by qPCR for the small mobile genetic element IS6110. The human ERV3 sequence was used as an internal control. 3 of 112 (3%) qPCR failed. For the remaining 109 samples, qPCR diagnosed tuberculosis in 79 of 84 patients with cultureproven tuberculosis, and sensitivity was greater than microscopy (94% versus 76%, respectively, P 0.05). The qPCR sensitivity was similar (P = 0.9) for smear-positive (94%, 60 of 64) and smear-negative (95%, 19 of 20) samples. The qPCR was negative for 24 of 25 of the sputa with negative microscopy and culture (diagnostic specificity 96%). The qPCR had 99.5% sensitivity and specificity for 211 quality control samples including 84 non-tuberculosis mycobacteria. The qPCR cost~5US$ per sample and provided same-day results compared with 2-6 weeks for culture.
INTRODUCTION
Although tuberculosis (TB) diagnosis may be assumed from clinical history and radiological findings, confirmation requires laboratory-based testing. Globally, TB laboratory diagnosis relies principally on smear microscopy that has low and variable sensitivity (50-80%) and suboptimal specificity. 1, 2 Culture followed by phenotypic identification and drug resistance testing is a "gold standard," 3, 4 but has the disadvantage of usually requiring several weeks and species. 5 In addition, final species identification requires additional phenotypic or genotypic testing, the latter not always being conclusive.
An alternative method for detection and/or species identification comprises the amplification of specific loci by polymerase chain reaction (PCR), which is theoretically capable of detecting a single copy of DNA from one cell. The PCR is used in the diagnosis of several infectious diseases and can give results in a few hours. For TB diagnosis, multiple commercial and in-house nucleic acid amplification techniques have been developed 6, 7 and recently, a commercial real-time PCR assay has been endorsed by the World Health Organization (WHO) (Xpert RIF/TB, GeneXpert, Cepheid, Canada) for the first time. 8 However, in-house PCR assays that use equipment and reagents that are available from diverse suppliers in competitive markets may be more affordable, feasible, and sustainable than using "sole-source" tests. We therefore aimed to develop and evaluate an in-house diagnostic real-time PCR using equipment and reagents that are widely available and a non-commercial sputum processing method. We included an internal control to try to increase reliability. The performance was evaluated in patients with suspected pulmonary TB by comparing results to direct smear microscopy and culture.
MATERIAL AND METHODS
Primer design. The primers and probe design was based on the sequence homology of the insertion sequence 6110 (IS6110) for all species of the Mycobacterium tuberculosis complex (MTBc). A 123 base pair (bp) region, which represents one of the highly conserved regions, was chosen as the target region for primer amplification. The fluorogenic BHQ-1 probe, labeled at 5 with FAM and at 3 with a dark quencher dye, was designed to anneal to an internal sequence of the amplified region. The sense and antisense primers and BHQ-1 probe were designated IS6110-TF, IS6110-TR, and IS6110-TP, respectively.
As an internal control to check for inhibition, a 105 bp region from ERV3 sequence was chosen as the target for primer amplification. 9 The fluorogenic BHQ-1 probe, labeled at 5 with HEX and at 3 with a dark quencher dye, was designed to anneal to an internal sequence of the amplified region. The sense and antisense primers and BHQ-1 probe were designated ERV3-TF, ERV3-TR, and ERV3-TP, respectively ( Table 1) . All primers and probes were designed using the AlleleID v. 7.0 software (PREMIER Biosoft, Palo Alto, CA).
DNA extraction. Samples for real-time PCR (qPCR) analysis (a 10 μL loop of mycobacterial isolate or 50 μL of decontaminated sputum) were heat inactivated at 95 C for 20 min and precipitated with 300 μL cold isopropanol, incubated overnight at −20 C, centrifuged (13,000 rpm for 10 min), washed once with ice cold absolute ethanol, and the pellet was resuspended in 100 μL TE 1X (Tris 10 mM, EDTA 1 mM, pH 8.0) buffer. One microliter (1 μL) of DNA solution was used in the qPCR.
qPCR assay. The PCR was performed using a LightCycler 480 Real-Time PCR System (Roche Applied Science, Penzberg, Germany). Each multiplex PCR assay was performed in a 10 μL final reaction volume containing 2 + SensiMix II Probe master (Bioline Reagents Ltd, London, UK). The following thermal profile was used: polymerase activation at 95 C for 10 min followed by 45 amplification cycles of 10 sec at 95 C and 1 min at 60 C each (annealing-extension step). A qPCR result for clinical specimens was considered negative if only a signal for ERV3 was observed, positive in *Address correspondence to Francesca Barletta, Instituto de Medicina Tropical Alexander von Humboldt Molecular Epidemiology Unit -TB Av. Honorio Delgado No, 430, San Martin de Porres. E-mail: francescabarletta@yahoo.es case of a positive IS6110 reaction irrespective of the presence of an ERV3 peak, and invalid if both the ERV3 and IS6110 reaction were negative. For qPCR the cycler threshold "C T " is the number of PCR cycles in which the PCR product starts to be detected and represents a relative measure of the concentration of target DNA in the PCR reaction. Data were collected at the annealing step of each cycle and the C T for each sample was calculated by determining the point at which the fluorescence exceeded the threshold limit. The IS6110 PCR was considered positive if the C T was 37 and the ERV3 PCR was considered positive if the C T was 40.
Analytical sensitivity. A pure culture of Mycobacterium tuberculosis reference strain Mt14323 10 was used to determine the detection limit (analytical sensitivity). Ten-fold serial dilutions from 10 7 to 1 fg (equivalent to 10 6 -10 genome copies) were prepared in triplicate from the genomic DNA, 11 and each of them was mixed with 5.4 ng of human DNA derived from 1.5 + 10 3 peripheral blood mononuclear cells from a volunteer. The standard curve was calculated automatically by plotting the C T values against each standard of known concentration and by extrapolating the linear regression line of this curve.
Quality control. Duplicate positive controls were included in all three of the PCR runs. We also analyzed 10 samples from the Quality Control Molecular Diagnostics 2012 M. tuberculosis external quality assessment panel (QCMD, Glasgow, UK) comprising eight positive controls containing M. tuberculosis in the concentration range 4-400 bacilli/10 μL in protein-rich buffer (0.1% Tween 20, 0.5% bovine serum albumin in phosphate buffered saline).
To assess the specificity of the qPCR all three runs included duplicate negative samples (no template control) to discriminate possible background. The external quality assessment panel also contained two negative control pooled specimens negative for MTBc. To assess the species specificity of the qPCR, we randomly selected 84 non-tuberculosis mycobacteria reference strains belonging to 35 species from the public collection of mycobacterial cultures (BCCM/ITM) ( Table 2) .
Clinical specimens. Single sputum samples were collected in Lima, Peru from patients (N = 112) with suspected TB who had been coughing for 15 days. Subjects were untreated TB patients with positive sputum smear microscopy (N = 64), patients with microscopy smear-negative sputum that was subsequently confirmed to be TB culture-positive (N = 20), and patients diagnosed as not having TB who subsequently had confirmatory negative TB smear microscopy and culture (N = 28).
Microbiology. An aliquot (1 mL) from each sample was decontaminated by the N-Acetyl-L-Cysteine-Sodium Hydroxide (NALC/NaOH) method, 12 and examined by Ziehl-Neelsen staining. 13, 14 A second aliquot (1 mL) of the same sample was decontaminated by the NaOH/NaCl (1:1 v/v) method, 15 Analysis. All laboratory procedures were performed by personnel who were blinded to sample details including the results of all other tests. The clinical sensitivity and specificity of the qPCR were calculated using 2 + 2 tables by comparing results to culture on Lö wenstein-Jensen medium that was considered to be the gold standard test. The 95% confidence intervals (95%CI) of proportions were calculated using the Stata program (version 12, StataCorp., College Station, TX).
Ethics. All human subjects gave informed written consent and the clinical protocols that involved sample preparation for diagnostics research were approved by the institutional ethics committee at the Universidad Peruana Cayetano Heredia and by the Regional Health Direction from the Ministry of Health. This laboratory research project used only anonymous unlinked specimens and therefore was exempted from human subjects research approval. None of the investigators have any conflict of interest in relation to this work.
RESULTS
Analytical sensitivity. Results of 10-fold serial dilutions are reported as C T numbers versus logs of starting quantities of DNA. The PCR efficiency was 1.9 with and without the presence of human DNA (Figure 1A and B) . The detection limit of this PCR assay was 10 fg of DNA/reaction which is equivalent to 1 bacillus ( Figure 2) .
Quality control. The results for the quality control samples are shown in Table 3 . All positive control samples yielded positive qPCR results and all no template controls were negative in all qPCR runs. Among the external quality assessment panel, the qPCR results were appropriate for all 8 of 8 posi-tive samples and 2 of 2 negative samples included as controls. All 84 non-tuberculosis mycobacteria reference strains were qPCR negative for IS6110. They were all negative for ERV3 internal control, which was expected because they were isolated from cultures that did not contain human DNA. Thus, for the 106 quality control samples the sensitivity was 100% (95% CI 78-100%) and specificity was 100% (95% CI 96-100%).
Clinical specimens. All Lö wenstein-Jensen cultures gave interpretable results and 100% (84 of 84) of TB cases were confirmed to be culture positive, whereas all samples from non-TB patients were culture negative. We obtained valid qPCR results in 109 of 112 samples; 3 of 112 (2.7%) others failed because they showed neither the product corresponding to the IS6110 sequence nor the product for the ERV3 internal control. For the valid results, qPCR analysis confirmed 94% (79 of 84) of the culture-positive samples, and predicted absence of TB DNA in 96% (24 of 25) of the negative samples. Hence, the qPCR had 94% (95% CI 90-98%) All quality control and clinical specimens. Considering together the 215 quality control and clinical specimens the qPCR accuracy is shown in Table 3 : sensitivity 95% (95% CI 89-98% and specificity 99% (95-100%).
Speed and cost. The use of real-time PCR provided diagnostic information within 24 hours from receipt of the clinical specimen. Excluding the expense of the qPCR thermocycler device self, the running costs (reagents and materials) of this MTBc assay were~US$5.00 for purchases in Peru.
DISCUSSION
Acid-fast bacilli (AFB) smear microscopy plays an important role in the early diagnosis of mycobacterial infections because it can be performed rapidly, within a few hours of sample collection, and requires only basic skills and equipment so it is often the only locally available diagnostic method in low-income countries. However, microscopy is prone to false negative results because it can only detect mycobacterial concentrations above~10,000 AFB/mL of specimen. Culture is more sensitive but may be hazardous to staff and results become available only after weeks of incubation.
The development of DNA probes for rapid detection of mycobacteria has been reported, and although they may be of use in identifying cultures of M. tuberculosis, they lack the sensitivity required for direct detection of the organism in specimen. [16] [17] [18] [19] [20] [21] [22] [23] [24] Currently, several assays are commercially available for the detection of the M. tuberculosis complex, including the Cobas Amplicor MTB PCR test (Roche Diagnostics, Basel, Switzerland), the RealArt Mycobact Diff Kit (Qiagen, Hamburg, Germany), 25 AMTD (Gen-Probe, Inc. San Diego, CA), 26 the Inno-LiPA line probe assay (Innogenetics, Ghent, Belgium), 27 the GenoType MTDRplus assay (Hain Lifescience, Nehren, Germany), 28 and the Xpert RIF/TB, GeneXpert, Cepheid, Canada). 8 These commercial assays are divided into two methods: conventional PCR followed by probe hybridization and real-time PCR. They require purified DNA by enzymatic lysis and phenol-chloroform extraction, ultrasound-based platforms or commercial kits. In this study, we used heating as the only agent to break down the bacteria and to release DNA followed by ethanol precipitation, which simplified the overall procedure, making the method potentially useful for routine clinical practice.
The IS6110 is an insertion element found exclusively within the members of the MTBc and, because of this exclusivity, it has become an important diagnostic tool in the identification of MTBc species. [29] [30] [31] McHugh and others 32 found that some non-tuberculosis mycobacteria (NTM) contain IS6110 homologs, which potentially could affect specificity; however, in our study none of the NTM amplified. Another benefit is that this sequence has been reported to be present in multiple copies in the genome. 33, 34 Because IS6110 can be found as several copies, our qPCR could detect as little as 0.01 pg of DNA/mL, which is equivalent . Threshold cycle indicates the number of cycles in which the PCR product was enough to be detected. Ten-fold serial dilutions were done from 10 7 to 10 fg (equivalent to 10 6 -10 genome copies) and were tested with (red) and without (blue) human DNA. The reaction efficiency was 99.9% for both curves. to 1 bacillus. This compares to Lö wenstein-Jensen culture, which detects 10-100 viable mycobacteria/mL of sample and the Gene Xpert System's MTB/RIF assay, which detects 131 colony-forming units (CFU)/mL. 35 The most sensitive limit of detection (LOD) theoretically possible is three copies per PCR, assuming a Poisson distribution. 36 The analytical sensitivity is defined as the concentration that can be detected with reasonable certainty (95% probability is commonly used) with a given analytical procedure.
Five culture-positive samples had false-negative PCR results and three samples from control subjects failed because they did not show amplification for the internal control. One of the latter samples was diluted 1/10 to decrease the possible presence of inhibitors, but the result remained negative. In addition to human error, poor amplification, or the lack of enough copies of IS6110 ( 3 copies), this could be explained by the presence of inhibitors of the amplifying system sample that may be observed in 2.9-20% of cases. 37 This assay provides added value over previously published in-house tests by inclusion of the ERV3 gene, an evolutionarily conserved single-copy human endogenous retrovirus with a coding envelope gene potentially involved in important placental functions. 38 The use of ERV3 as an internal control 39 will identify the presence of false negative PCR results caused by contamination and/or inhibition.
We simplified DNA extraction to use only heat and ethanol precipitation, potentially facilitating implementation in resource-poor settings and avoiding the high cost of commercial kits for DNA isolation. 6, 40 To avoid sole-source reagents and equipment that can be difficult to import, afford, and sustain in some settings, we used a TaqMan real-time PCR assay and obtained sensitivity similar to the much slower Lö wenstein-Jensen culture.
Excluding the expense of the qPCR thermocycler device self, the running costs (reagents and small materials) of this MTBc assay are~US$5.00, lower than the Xpert RIF/TB (US$10.00-$100 in different American countries) and the Hain Assay (US$10.00 in Peru).
Thus, the real-time PCR proposed in this study, showed a high level of specificity and sensitivity, short turn-around time, and relatively low cost. These results justify further evaluation of this relatively simple, low-cost test to determine diagnostic reliability in operational settings.
